These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1884142)

  • 1. Cystoscopic suction diathermy for the treatment of superficial bladder tumours.
    Bunce CJ; Dev Sarmah B; Considine J
    Br J Urol; 1991 Aug; 68(2):157-61. PubMed ID: 1884142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of superficial bladder tumours under local anaesthetic using suction diathermy electrodes.
    Bunce CJ; Sarmah BD; Considine J
    Eur Urol; 1994; 25(1):76-8. PubMed ID: 8307081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.
    van der Heijden AG; Kiemeney LA; Gofrit ON; Nativ O; Sidi A; Leib Z; Colombo R; Naspro R; Pavone M; Baniel J; Hasner F; Witjes JA
    Eur Urol; 2004 Jul; 46(1):65-71; discussion 71-2. PubMed ID: 15183549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder.
    Wedderburn AW; Ratan P; Birch BR
    J Urol; 1999 Mar; 161(3):812-4. PubMed ID: 10022690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of radiofrequency hyperthermia for treating advanced urinary bladder cancer--a case report].
    Kubota Y; Takebayashi S; Asakura K; Oshima H
    Gan No Rinsho; 1984 Feb; 30(2):215-9. PubMed ID: 6200623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of invasive bladder cancer by local resection and high dose methotrexate.
    Hall RR; Newling DW; Ramsden PD; Richards B; Robinson MR; Smith PH
    Br J Urol; 1984 Dec; 56(6):668-72. PubMed ID: 6534487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of prognostic factors of superficial bladder cancer treated with intravesical bacillus Calmette-Guerin.
    Shinka T; Hirano A; Uekado Y; Ohkawa T
    Br J Urol; 1990 Jul; 66(1):35-9. PubMed ID: 2393797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder.
    Konety BR; Williams RD
    BJU Int; 2004 Jul; 94(1):18-21. PubMed ID: 15217424
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of transitional cell carcinoma of the bladder.
    Murshidi MS
    Arch Esp Urol; 1989 Mar; 42(2):172-5. PubMed ID: 2735783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
    Lipiński MI; Jeromin LM
    Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 bladder tumours.
    Williams JL; Hammonds JC; Saunders N
    Br J Urol; 1977; 49(7):663-8. PubMed ID: 597705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: an investigational approach.
    Luciani LG; Neulander E; Murphy WM; Wajsman Z
    Urology; 2001 Sep; 58(3):376-9. PubMed ID: 11549484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic perfusion of the distended urinary bladder in the management of recurrent transitional cell carcinoma.
    Ludgate CM; McLean N; Carswell GF; Newsam JE; Pettigrew RT; Tulloch WS
    Br J Urol; 1975; 47(7):841-8. PubMed ID: 1222351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder.
    Flamm J; Bucher A
    Br J Urol; 1991 Jan; 67(1):70-3. PubMed ID: 1993279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.